Type II

Childhood Pancreatitis May Increase Chances for Type 2

Children who have had an episode of acute pancreatitis may have an increased risk for developing type 2 diabetes before the age of 40, researchers say. Read more

The Flu Increases Hospitalization Risk for Type 2 Patients

Serious influenza complications can result in a higher risk of hospitalization, and also mortality, in patients with diabetes. The influenza virus, commonly known as the flu, has the potential of exacerbating chronic health problems that lead to worsening the disease state of diabetes. Read more

The Complex Relationship Between Type 2 and Alzheimer’s

Researchers may be only beginning to understand how Alzheimer’s disease and type 2 diabetes could be linked. Deciphering the connection could lead to earlier Alzheimer’s diagnosis and better treatments for both diseases. The connection involves how the brain metabolizes blood sugar and the factors that influence that process, including diet, sleep, and cardiovascular health.   […]

First Oral GLP-1 For Type 2 Diabetes: Rybelsus

Oral semaglutide, brand name Rybelsus, is the first GLP-1 agonist that can be taken by mouth rather than requiring an injection. Studies have shown a significant reduction in A1c, a reduction in cardiovascular disease, and a reduction in weight, without the risk of hypoglycemia, for this drug. Patients must carefully follow instructions for taking the […]

FDA Approval of Invokana for Kidney Disease “First Major Breakthrough in 20 Years”

The FDA has approved a new treatment of Invokana for diabetic chronic kidney disease (CKD), which affects one in three patients with type 2 diabetes. CKD increases the risk for serious cardiovascular events and end-stage renal disease in patiens with type 2 diabetes. The approval of Invokana meets a 20 year need for therapy to […]

Reversing Metabolic Syndrome and Preventing Type 2

Metabolic syndrome (MetS) is a set of interconnected biochemical, clinical, and metabolic factors that increase risk of heart disease and type 2 diabetes. Characteristics of MetS include high blood pressure, high blood glucose, and excess body fat around the waist. Carbohydrate intake stimulates insulin secretion, which in turn stimulates fat storage, is linked to MetS. […]

Sugar Substitutes and Type 2

Many people who drink lots of sugary beverages typically switch to diet sodas when diagnosed with type 2 diabetes, because they have no sugar and are supposed to be “healthier.” However, new evidence is showing that diet soda may actually contribute to a person’s diabetes. Read more

All About Double Diabetes

Double diabetes or double disease (DD) refers to having type 1 diabetes (T1D) along with insulin resistance, a characteristic of type 2 diabetes (T2D). Clear criteria to define this group of patients is not very well established. Read more

Type 2 Remission through Moderate Weight Loss

Losing as little as 10% of body weight within the first few years following a type 2 diabetes diagnosis can actually send the condition into remission — that is, a decrease or even disappearance of symptoms, allowing people to cease taking medication — according to a new study. Read more

Liraglutide and Gall Bladder Issues

In addition to glycemic control, liraglutide also promotes weight loss, which can be helpful in patients with obesity and type 2 diabetes. However, development of gallstones may be a common side effect in patients that are on liraglutide for the treatment of their type 2 diabetes. Read more

Thyroid Disorders Linked to Type 2 Diabetes

Thyroid hormones are essential for carbohydrate metabolism, thus, thyroid dysfunctions can influence the development of type 2 diabetes. A large, nation-wide study investigated the effects of thyroid disorders on the occurrence of type 2 diabetes. Read more

FDA Approves Oral Semaglutide for Type 2 Diabetes

The U.S. Food and Drug Administration (FDA) has approved a new medication, Rybelsus (semaglutide) oral tablets, for use in controlling blood sugar in adults with type 2 diabetes, along with diet and exercise. Rybelsus is the first medication in the glucagon-like peptide (GLP-1) receptor class that does not need to be injected to be approved […]

New Eye Scan Could Help Predict Diabetes

New research says that specialist analysis of the lens in the eye can predict which patients may develop type 2 diabetes or impaired glucose tolerance (IGT) or prediabetes. The study used a newly developed biomicroscope which can detect advanced glycation end-products (AGEs) in the eye via a simple scan. Read more

Shorter People at Greater Risk for Type 2 Diabetes

Taller people are at less risk for type 2 diabetes, according to a new study from Germany. For every 10 centimeters of additional height, there was a 41% reduced risk of type 2 in men and a 33% reduced risk in women, after adjusting to remove the potential effects of age, education, lifestyle, and waist […]

Are Rates of Type 2 Stabilizing?

A new study suggests that the number of new cases of type 2 diabetes could be stabilizing, or even falling, in many countries. The analysis looked at 47 studies from the mid-1960s through 2014, from the U.S., Canada, and multiple European countries. One third of the groups studied between 2006 and 2014 saw a reduction […]

Gene Editing for Obesity and Diabetes?

Researchers are looking into the possibility of using a modified CRISPR gene editing technique to target fat cells, potentially improving weight loss by exploiting how cells use their genetic code. Read more

Healthcare Provider Empathy Affects Mortality

New research examined the association between provider empathy in the first year of type 2 diabetes diagnosis and incidence of cardiovascular events and all-cause-mortality in patients with type 2 diabetes over ten years. Read more

Study Looks at Lifestyle Changes for Diabetes Remission

A recent study compared intensive exercise-based lifestyle interventions versus standard therapy to see which, if either, performed better in achieving sustained diabetes remission. Read more

Two Diabetes Drugs Show Benefits for Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) often occurs in patients with type 2 diabetes. A recent study showed that the diabetes medications liraglutide and sitagliptin, in combination with metformin, can improve intrahepatic lipid and therefore benefit NAFLD. Read more

Treating PTSD can Reduce Type 2 Risk

Treatment of Post-Traumatic Stress Disorder (PTSD) that successfully reduces symptoms may also help reduce the risk for developing type 2 diabetes, researchers have found. PTSD is associated with increased risk of type 2, possibly due to the high rates of obesity, glucose dysregulation, inflammation, metabolic syndrome and depression among those diagnosed with PTSD. Read more